Temporal muscle thickness is associated with immunotherapy outcomes in head and neck squamous cell carcinoma
Hirotaka Eguchi, Kiyohito Hosokawa, Ryota Kawano, Yukinori Takenaka, Hiroshi Kato, Toshihiro Kishikawa, Masami Suzuki, Motoyuki Suzuki · 2026
Read Temporal muscle thickness is associated with immunotherapy outcomes in head and neck squamous cell carcinoma by Hirotaka Eguchi, Kiyohito Hosokawa, Ryota Kawano, Yukinori Takenaka, Hiroshi Kato, Toshihiro Kishikawa, Masami Suzuki, Motoyuki Suzuki (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0356013.txt.
Description
Hirotaka Eguchi and colleagues asked whether the thickness of the temple muscle, visible on routine head scans, predicts immunotherapy success. Muscle loss can weaken response to immune checkpoint drugs in returning head and neck cancer. Their 2026 study measured the muscle in just over a hundred patients treated with two such drugs.
Patients with thicker temple muscles responded to treatment more often than those with thinner muscles. One year on, both freedom from progression and survival were clearly better in the thicker-muscle group. The link held after adjusting for chemotherapy use. Eguchi and colleagues propose the measurement, free on scans patients already receive, as a simple marker for sorting patients by likely outcome.
Catalog record
| CREATOR | Hirotaka Eguchi, Kiyohito Hosokawa, Ryota Kawano, Yukinori Takenaka, Hiroshi Kato, Toshihiro Kishikawa, Masami Suzuki, Motoyuki Suzuki |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 25464 |
| LICENSE | CC_BY |
| RIGHTS | CC BY |
| SOURCE | PLOS |